Adjuvants in Allergen-Specific Immunotherapy: Modulating and Enhancing the Immune Response

• Published in: Journal of investigational allergology & clinical immunology Vol. 29; no. 2; pp. 103 - 111
• Main Authors: Zubeldia, J M, Ferrer, M, Dávila, I, Justicia, J L
• Format: Journal Article
• Language: English
• Published: Spain Esmon Publicidad 01.01.2019
• Subjects: Adjuvants; Allergens; Allergic diseases; Allergic rhinitis; Allergies; Aluminum; Aluminum hydroxide; Animal models; Asthma; Biodegradability; Calcium hydroxide; Calcium phosphates; Food allergies; Hyperreactivity; Immune response; Immunoglobulin E; Immunoglobulin G; Immunomodulation; Immunostimulation; Immunotherapy; Lipid A; Liposomes; Monophosphoryl lipid A; Nanoparticles; Phosphatidylserine; Pollen; Polymers; Virus-like particles; Nanoparticles; Allergen-specific immunotherapy; Aluminum hydroxide; Calcium phosphate; Adjuvant; Microcrystalline tyrosine; Monophosphoryl lipid A; Asthma; Immunostimulatory sequences
• ISSN: 1018-9068; 1698-0808
• DOI: 10.18176/jiaci.0349

Allergen-specific immunotherapy (AIT) is the only treatment that can affect the natural course of allergic diseases such as allergic asthma, allergic rhinitis, and IgE-mediated food allergy. Adjuvants are used to induce a quicker, more potent, and longer-lasting immune response. Only 4 compounds are used as adjuvants in currently marketed AIT products: aluminum hydroxide, calcium phosphate, microcrystalline tyrosine (MCT), and monophosphoryl lipid A (MPL). The first 3 adjuvants are delivery systems with a depot effect, although they may also have immunomodulatory properties. These first-generation adjuvants are still widely used, especially aluminum hydroxide. However, aluminum is subject to limitations. MCT is the depot formulation of L-tyrosine; it enhances IgG production without inducing a significant increase in IgE, is biodegradable, and has good local and systemic tolerability. In turn, MPL is an immunostimulatory agent that is the only second-generation adjuvant currently used for AIT. In addition, multiple adjuvants are currently being studied, including immunostimulatory sequences (ISSs), nanoparticles (liposomes, virus-like particles, and biodegradable polymers), and phosphatidylserine derivatives. In a murine model of allergic bronchial inflammation by sensitization to olive pollen, the specific IgE level was significantly higher in sensitized mice treated with olive pollen and aluminum hydroxide. However, specific IgE levels were significantly reduced and bronchial hyperreactivity significantly improved in sensitized mice treated with olive pollen and bacterial derivatives (MPL or ISSs).